Nine IPOs raised $5.8 billion during the week of September 22, the IPO market's third-highest capital raise of the year behind a surge in late-July and the week of September 15, where Alibaba (BABA) raised $21.8 billion. The week of September 22 saw the...read more
Six companies went public Wednesday as 2014 reached a milestone of over 200 IPOs, the most since 2000 and a 41% increase over last year. With nearly 20 IPOs on the...read more
Vitae Pharmaceuticals, which is developing small molecule drugs for type 2 diabetes and Alzheimer's, raised $55 million by offering 6.9 million shares at $8, well below its $11-$13 price range. The Fort Washington, PA-based company had initially planned to raise...read more
US IPO Pricing Recap: CyberArk Software pops 85% and year's second largest IPO trades up
Nine IPOs raised $5.8 billion during the week of September 22, the IPO market's third-highest capital raise of the year behind a surge in late-July and the week of September 15, where Alibaba (BABA) raised $21.8 billion. The week of September 22 saw the...read more
2014 IPO market hits 200
Six companies went public Wednesday as 2014 reached a milestone of over 200 IPOs, the most since 2000 and a 41% increase over last year. With nearly 20 IPOs on the...read more
Vitae Pharmaceuticals prices IPO at $8, well below the range; slashes valuation by 27%
Vitae Pharmaceuticals, which is developing small molecule drugs for type 2 diabetes and Alzheimer's, raised $55 million by offering 6.9 million shares at $8, well below its $11-$13 price range. The Fort Washington, PA-based company had initially planned to raise...read more
14 US IPOs planned for the week of September 22, including the year's second-largest
On the heels of Alibaba's (BABA) successful debut, the upcoming week could prove to be a litmus...read more